American Academy of Pediatrics

TABLE 1

Patient Characteristics

	Value
Age, median (range)	11 y (2 mo to 23 y)
Sex (N = 50), % of total
Male	56
Female	44
Diagnosis (N = 50), % of total
Cancer	80
Leukemia	26
CNS tumor	14
Solid tumor	40
Cystic fibrosis	6
Seizure disorder	6
Other	8
Reason for use or potential use (>1 possible per patient), % of total
Nausea and vomiting	40
Appetite stimulation	36
Pain	38
Seizures	6
Anticancer	20
Other	14
Product used (N = 50), % of total
Tetrahydrocannabinol only	6
Cannabidiol only	20
Tetrahydrocannabinol and cannabidiol combination	12
No product at time of consultation	62

	Value
Age, median (range)	11 y (2 mo to 23 y)
Sex (N = 50), % of total
Male	56
Female	44
Diagnosis (N = 50), % of total
Cancer	80
Leukemia	26
CNS tumor	14
Solid tumor	40
Cystic fibrosis	6
Seizure disorder	6
Other	8
Reason for use or potential use (>1 possible per patient), % of total
Nausea and vomiting	40
Appetite stimulation	36
Pain	38
Seizures	6
Anticancer	20
Other	14
Product used (N = 50), % of total
Tetrahydrocannabinol only	6
Cannabidiol only	20
Tetrahydrocannabinol and cannabidiol combination	12
No product at time of consultation	62

CNS, central nervous system.